Massachusetts H2372 allows collaborative drug therapy management in ambulatory care clinics with physician and pharmacist supervision.

Massachusetts H2372 amends existing law to permit collaborative drug therapy management in ambulatory care clinics. This management must be supervised by an attending physician and a collaborating pharmacist. Additionally, the management must be approved by the clinic's medical staff executive committee or medical director. This change aims to optimize drug therapy management in licensed ambulatory care clinics.

Massachusetts H2372 allows collaborative drug therapy management in ambulatory care clinics with physician and pharmacist supervision.

Massachusetts H2372 amends existing law to permit collaborative drug therapy management in ambulatory care clinics. This management must be supervised by an attending physician and a collaborating pharmacist. Additionally, the management must be approved by the clinic's medical staff executive committee or medical director. This change aims to optimize drug therapy management in licensed ambulatory care clinics.